PapersOthers（Reference ducuments）Limited proteolysis Sho Masui et al.(2023) [nSMOL] Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis Biol. Pharm. Bull. 46, 1112–1119 (2023) 論文・技術情報一覧に戻る
PAGE TOP